title: [The interferon alfa-2a treatment of the severe form of the Kasabach-Merritt syndrome with neonatal onset].
authors.affiliation: Servicio de Pediatría, Hospital Universitario San Juan, Alicante.
authors.forename: J
authors.initials: J
authors.lastname: González de Dios
authors.forename: M
authors.initials: M
authors.lastname: Moya Benavent
authors.forename: Y
authors.initials: Y
authors.lastname: Herranz Sánchez
authors.forename: M
authors.initials: M
authors.lastname: Juste Ruiz
authors.forename: R
authors.initials: R
authors.lastname: González Montero
mesh_terms: D000208:Acute Disease; D003131:Combined Modality Therapy; D018450:Disease Progression; D004211:Disseminated Intravascular Coagulation / Q000628:therapy; D005260:Female; D006392:Hemangioma, Cavernous / Q000628:therapy*; D006801:Humans; D007231:Infant, Newborn; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D010307:Parotid Neoplasms / Q000628:therapy*; D011994:Recombinant Proteins; D013577:Syndrome; D013921:Thrombocytopenia / Q000628:therapy*
chemical_list: D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins